Fedotova Evgeniya I, Berezhnov Alexey V, Popov Daniil Y, Shitikova Elena Y, Vinokurov Andrey Y
Institute of Cell Biophysics of the Russian Academy of Sciences, Pushchino 142290, Russia.
Cell Physiology and Pathology Laboratory, Orel State University, Orel 302026, Russia.
Int J Mol Sci. 2025 Jan 25;26(3):1019. doi: 10.3390/ijms26031019.
Atherosclerosis is a complex inflammatory process associated with high-mortality cardiovascular diseases. Today, there is a growing body of evidence linking atherosclerosis to mutations of mitochondrial DNA (mtDNA). But the mechanism of this link is insufficiently studied. Atherosclerosis progression involves different cell types and macrophages are one of the most important. Due to their high plasticity, macrophages can demonstrate pro-inflammatory and pro-atherogenic (macrophage type M1) or anti-inflammatory and anti-atherogenic (macrophage type M2) effects. These two cell types, formed as a result of external stimuli, differ significantly in their metabolic profile, which suggests the central role of mitochondria in the implementation of the macrophage polarization route. According to this, we assume that mtDNA mutations causing mitochondrial disturbances can play the role of an internal trigger, leading to the formation of macrophage M1 or M2. This review provides a comparative analysis of the characteristics of mitochondrial function in different types of macrophages and their possible associations with mtDNA mutations linked with inflammation-based pathologies including atherosclerosis.
动脉粥样硬化是一种与高死亡率心血管疾病相关的复杂炎症过程。如今,越来越多的证据表明动脉粥样硬化与线粒体DNA(mtDNA)突变有关。但这种联系的机制尚未得到充分研究。动脉粥样硬化的进展涉及不同类型的细胞,其中巨噬细胞是最重要的细胞之一。由于其高度可塑性,巨噬细胞可表现出促炎和促动脉粥样硬化作用(M1型巨噬细胞)或抗炎和抗动脉粥样硬化作用(M2型巨噬细胞)。这两种因外部刺激而形成的细胞类型,其代谢特征有显著差异,这表明线粒体在巨噬细胞极化途径的实现中起核心作用。据此,我们假设导致线粒体功能紊乱的mtDNA突变可能起内部触发因素的作用,导致M1或M2型巨噬细胞的形成。本综述对不同类型巨噬细胞中线粒体功能的特征及其与包括动脉粥样硬化在内的基于炎症的病理相关的mtDNA突变的可能关联进行了比较分析。
Acta Biochim Biophys Sin (Shanghai). 2020-9-8
Arterioscler Thromb Vasc Biol. 2021-2
Genes (Basel). 2022-4-25
Front Immunol. 2024
Cell. 2024-5-23
Front Immunol. 2024-4-10